River Vest Venture Management LLC Xilio Therapeutics, Inc. Transaction History
River Vest Venture Management LLC
- $6.84 Billion
- Q3 2024
A detailed history of River Vest Venture Management LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, River Vest Venture Management LLC holds 1,441,444 shares of XLO stock, worth $1.27 Million. This represents 16.6% of its overall portfolio holdings.
Number of Shares
1,441,444
Previous 1,441,444
-0.0%
Holding current value
$1.27 Million
Previous $1.37 Billion
16.87%
% of portfolio
16.6%
Previous 20.01%
Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
34Shares Held
14MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$4.02 Million0.65% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3MShares$2.64 Million0.08% of portfolio
-
Morgan Stanley New York, NY1.52MShares$1.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$794,2270.0% of portfolio
-
Aju Ib Investment Co., Ltd. Seoul, M5668KShares$587,6123.33% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $24.2M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...